Bio Works (Sweden) Investor Sentiment

BIOWKS Stock  SEK 1.46  0.02  1.35%   
About 61% of Bio Works' investor base is looking to short. The analysis of current outlook of investing in Bio Works Technologies AB suggests that many traders are alarmed regarding Bio Works' prospects. The current market sentiment, together with Bio Works' historical and current headlines, can help investors time the market. In addition, many technical investors use Bio Works Technologies stock news signals to limit their universe of possible portfolio assets.
  
over a year ago at news.google.com         
Nordea Investment Management AB Buys 727417 Shares of Ginkgo Bioworks Holdings, Inc. - MarketBeat
Google News at Macroaxis
over a year ago at news.google.com         
Bio-Works expands product range with introduction of WorkBeads 40 Butyl SH - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
The nomination committees proposal regarding election of board members of Bio-Works - Marketscreener...
Google News at Macroaxis
over a year ago at news.google.com         
6 Stocks Cathie Wood Is Buying - msnNOW
Google News at Macroaxis
over a year ago at news.google.com         
Bio-Works receives second order worth 2.4 MSEK order from customer in Netherlands - Marketscreener.c...
Google News at Macroaxis
over a year ago at news.google.com         
Bio-Works Technologies Books SEK1.9 Million Workbeads Resin Order - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Arena BioWorks Launches as a Privately Funded, Fully Independent Biomedical Institute to Shorten the...
Google News at Macroaxis
over a year ago at news.google.com         
Bioservo to be delisted from Nasdaq First North - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
WorkBeads enable scale-up of Nemysis Ltds nutritional deficiency candidates - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Companies Like Bio-Works Technologies Are In A Position To Invest In Growth - Simply Wall St
Google News at Macroaxis
over a year ago at news.google.com         
Liquidator appointed in Bioservo -December 20, 2023 at 1001 am EST - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
2 Cathie Wood Stocks That Might Be Smart Buys Right Now - EMEA Tribune, Breaking News, World News, L...
Google News at Macroaxis
over a year ago at news.google.com         
5 Beaten-Down Stocks That Could Soar in 2024 - EMEA Tribune, Breaking News, World News, Latest News,...
Google News at Macroaxis
over a year ago at news.google.com         
AI is in the early stages of upending the drug discovery and development process, but there will sti...
Google News at Macroaxis
over a year ago at news.google.com         
Arbor Biotechnologies Announces Collaboration with Ginkgo Bioworks to Advance the Discovery and Deve...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Bio Works that are available to investors today. That information is available publicly through Bio media outlets and privately through word of mouth or via Bio internal channels. However, regardless of the origin, that massive amount of Bio data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Bio Works news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Bio Works relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Bio Works' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Bio Works alpha.

Bio Works Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Bio Stock analysis

When running Bio Works' price analysis, check to measure Bio Works' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Works is operating at the current time. Most of Bio Works' value examination focuses on studying past and present price action to predict the probability of Bio Works' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Works' price. Additionally, you may evaluate how the addition of Bio Works to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years